TEVA Profile
Teva Pharmaceutical Industries Limited, headquartered in Tel Aviv-Yafo, Israel, is a global pharmaceutical powerhouse specializing in the development, manufacturing, marketing, and distribution of a wide range of healthcare products. Established in 1901, Teva operates extensively across North America, Europe, and international markets.
The company's diverse product portfolio includes generic medicines, specialty pharmaceuticals, and biopharmaceuticals across various therapeutic areas. Teva's offerings encompass sterile products, hormones, high-potency drugs, and cytotoxic substances, available in multiple dosage forms such as tablets, capsules, injectables, inhalants, and topical formulations like ointments and creams. Additionally, Teva is a key player in the active pharmaceutical ingredients (API) sector, ensuring a robust supply chain and vertical integration.
Teva Pharmaceutical Industries focuses its research and development efforts on therapeutic areas critical to global healthcare needs. Key areas of focus include central nervous system disorders, pain management, respiratory ailments, and oncology. Notable products in its portfolio include Copaxone for multiple sclerosis, AJOVY for migraine prevention, and AUSTEDO for conditions like tardive dyskinesia and Huntington disease.
In the respiratory segment, Teva offers a range of treatments such as ProAir, QVAR, and various Digihaler products, addressing asthma and chronic obstructive pulmonary disease (COPD). In oncology, Teva provides important therapies like Bendeka, Treanda, and Granix, bolstering its commitment to advancing cancer care globally. The company also collaborates with partners like MedinCell to develop and commercialize innovative long-acting injectable products, expanding its therapeutic footprint and enhancing patient outcomes worldwide.
|
